Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

3 steel stocks to play the manufacturing comeback: https://www.marketbeat.com/logos/articles/med_20240122063321_3-steel-stocks-to-play-the-manufacturing-comeback.jpg
3 steel stocks to play the manufacturing comeback

Every new cycle brings on a new set of opportunities to investor portfolios, and markets provide new waves of shifts between sector performances. Today's market is different from the one you

Will ServiceNow continue its streak of double-digit EPS growth?: https://www.marketbeat.com/logos/articles/med_20240121202202_will-servicenow-continue-its-streak-of-double-digi.jpg
Will ServiceNow continue its streak of double-digit EPS growth?

Enterprise cloud software stocks are some of the market’s top leaders, having rallied back in a big way in 2023 after a dismal 2022. That uptrend is continuing, as stocks like Datadog Inc.

3 undervalued stocks: Is now the right time to buy?: https://www.marketbeat.com/logos/articles/med_20240122061313_3-undervalued-stocks-is-now-the-right-time-to-buy.jpg
3 undervalued stocks: Is now the right time to buy?

For savvy investors, hunting down undervalued stocks can mean unearthing overlooked stocks with big potential. In any market cycle, undervalued stocks are there, waiting to be scooped up at

Need yield? 3M stock has it, plus 5.0% upside: https://www.marketbeat.com/logos/articles/med_20240122062111_need-yield-3m-stock-has-it-plus-5.jpg
Need yield? 3M stock has it, plus 5.0% upside

Everyone pretty much is aware that the FED has taken a different stance to their interest rate trajectory for this year. Whereas they focused on hiking interest rates during 2023 to combat

nCino's path to profits: Niche fintech with strong prospects: https://www.marketbeat.com/logos/articles/med_20240121201956_ncinos-path-to-profits-niche-fintech-with-strong-p.jpg
nCino's path to profits: Niche fintech with strong prospects

You’ve probably noticed: The banking industry is moving away from branch visits, and toward “there’s an app for that.” 

Not only are consumers using apps like PayPal Holdings Inc. (NASDAQ: PYPL)

3 airline stocks you can buy the dip on: https://www.marketbeat.com/logos/articles/med_20240122060921_3-airline-stocks-you-can-buy-the-dip-on.jpg
3 airline stocks you can buy the dip on

There's always a dip somewhere in the world that investors with a lot of dry powder (cash buying power) patiently wait to deploy their assets into good deals. Who would have thought that the most

Energy sector's risk-off stance, underperformance so far in 2024: https://www.marketbeat.com/logos/articles/med_20240119081534_energy-sectors-risk-off-stance-underperformance-so.jpg
Energy sector's risk-off stance, underperformance so far in 2024

In the early days of 2024, the SPDR S&P 500 ETF Trust (NYSE: SPY) is soaring near its all-time high, primarily driven by the impressive rally in the technology sector. Over the past month, it has

How do T-Mobile, AT&T & Verizon look ahead of earnings?: https://www.marketbeat.com/logos/articles/med_20240118185012_how-do-t-mobile-att-verizon-look-ahead-of-earnings.jpg
How do T-Mobile, AT&T & Verizon look ahead of earnings?

Telecom stocks as a group are entering 2024 as “middle-of-the-pack” players. 

Relative to the broader Communication Services Select Sector SPDR Fund (NYSEARCA: XLC), telecoms as a group lagged in

Qualcomm stock poised for breakout: https://www.marketbeat.com/logos/articles/med_20240118081143_qualcomm-stock-poised-for-breakout.jpg
Qualcomm stock poised for breakout

Compared to some of the other chipmakers, Qualcomm Inc (NASDAQ: QCOM) has been trading a little slower in recent weeks. While the likes of Advanced Micro Dynamics, Inc (NASDAQ: AMD) are up 70%

Is the bottom in for bellwether Alcoa?: https://www.marketbeat.com/logos/articles/med_20240118073212_chart-aa-1182024ver001.png
Is the bottom in for bellwether Alcoa?

Alcoa’s (NYSE: AA) prominence as a bellwether of the US economy faded over the last decade but should not be discounted. Alumina, aluminum, and the products made from them are leading indicators

Microsoft Stock: Telecom triumph a $1.5 billion game-changer: https://www.marketbeat.com/logos/articles/med_20240117134846_microsoft-stock-telecom-triumph-a-1.jpg
Microsoft Stock: Telecom triumph a $1.5 billion game-changer

In a move that marks a significant milestone in the telecommunications industry, Microsoft (NASDAQ: MSFT) has announced a groundbreaking $1.5 billion deal with Vodafone (NASDAQ: VOD), setting a

Oil is in contango for the first time since 2021: Best oil stocks: https://www.marketbeat.com/logos/articles/med_20240116145917_oil-is-in-contango-for-the-first-time-since-2021-b.jpg
Oil is in contango for the first time since 2021: Best oil stocks

The days of open outcry commodity trading are nearly extinct, as most of today's trading takes place behind a desk and through online brokerages. However, the traders that ascended from these pits

MAX 9 may not affect Boeing's earnings; should you buy the dip?: https://www.marketbeat.com/logos/articles/med_20240116122451_max-9-may-not-affect-boeings-earnings-should-you-b.jpg
MAX 9 may not affect Boeing's earnings; should you buy the dip?

Good traders ride the trend; they were the ones who came up with the saying, "The trend is your friend." 

While they may successfully ride the waves in the big market movers, those who take on

3 downgraded names you can buy into: https://www.marketbeat.com/logos/articles/med_20240116115940_3-downgraded-names-you-can-buy-into.jpg
3 downgraded names you can buy into

A downgrade isn't necessarily bad, just like an upgrade isn't always a reason to buy. 

Sometimes, downgrades or downward revisions to price targets are a natural and healthy part of market

3 high yield stock ETFs that make any income portfolio better: https://www.marketbeat.com/logos/articles/med_20240117070534_3-high-yield-stock-etfs-that-make-any-income-portf.jpg
3 high yield stock ETFs that make any income portfolio better

When preparing a winning meal, careful selection of the right ingredients is paramount. The same can be said about building a winning investment portfolio.

Once a money-making strategy has been

Are CVS store closures prescription for better financial health?: https://www.marketbeat.com/logos/articles/med_20240117070137_are-cvs-store-closures-prescription-for-better-fin.jpg
Are CVS store closures prescription for better financial health?

After CVS Health Corp. (NYSE: CVS) said it would shutter dozens of pharmacies in Target Corp. (NYSE: TGT) stores, the stock immediately declined by 3%, but in the January 16 session was bucking

UnitedHealth's rising premiums could cushion stubborn inflation: https://www.marketbeat.com/logos/articles/med_20240116085908_unitedhealths-rising-premiums-could-cushion-stubbo.jpg
UnitedHealth's rising premiums could cushion stubborn inflation

When markets become uncertain about the economy's direction and stocks trend in a bumpy and indecisive pattern, some sectors usually attract investment dollars because of their perceived safety.

Solo Brands cooked on 2023 guidance cut. Is it a bargain or trap?: https://www.marketbeat.com/logos/articles/med_20240115133806_solo-brands-cooked-on-2023-guidance-cut.png
Solo Brands cooked on 2023 guidance cut. Is it a bargain or trap?

Outdoor and lifestyle products maker Solo Brands Inc. (NASDAQ: DTC) has grown a cultlike following under its many brands. The consumer discretionary sector company initially started by offering an

Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73280/AC_Vidac_170124.001.png
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. 133% Biotech Aktientip nach 15.973%

 

17.01.24 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Time to buy these 3 healthcare companies that raised revenue guidance?: https://www.marketbeat.com/logos/articles/med_20240114165541_chart-exas2.jpg
Time to buy these 3 healthcare companies that raised revenue guidance?

The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare

PayPal gearing up for a breakout despite shifting sentiment: https://www.marketbeat.com/logos/articles/med_20240115120327_paypal-gearing-up-for-a-breakout-despite-shifting.jpg
PayPal gearing up for a breakout despite shifting sentiment

Few names outperformed PayPal Holdings Inc. (NASDAQ: PYPL) during the COVID-19 pandemic. Imagine a company that not only weathered the storm of the COVID-19 pandemic but thrived amidst the chaos,

Power Plays: MSFT, NVDA, GOOGL, META dominate market moves: https://www.marketbeat.com/logos/articles/med_20240115072106_power-plays-msft-nvda-googl-meta-dominate-market-m.jpg
Power Plays: MSFT, NVDA, GOOGL, META dominate market moves

Last week, an interesting picture of triumph was painted in the stock market, with the technology sector taking the lead. Now, this may come as no surprise. The stars of the show were none other

Bitcoin ETFs: A two-day ranking of top performers: https://www.marketbeat.com/logos/articles/med_20240115114740_bitcoin-etfs-a-two-day-ranking-of-top-performers.jpg
Bitcoin ETFs: A two-day ranking of top performers

The recent approval and launch of eleven Bitcoin spot ETFs have added a thrilling chapter. Building up to the much-anticipated approval, the market was brimming with anticipation. 

As the U.S.

Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73259/Aktiencheck160124.001.png
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. 152% Biotech Aktientip nach 134.452% mit Biogen

 

16.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)